Jason Mills

Medtronic, CBOE, Lindt, Grey Sail: Intellectual Property

Medtronic Inc. lost its bid to overturn a $74 million jury verdict won by Edwards Lifesciences Corp. and may face a court order halting production of some of its CoreValve heart valves.

Medtronic Loses Appeal in $74 Million Edwards Patent Case

Medtronic Inc. lost its bid to overturn a $74 million jury verdict won by Edwards Lifesciences Corp. and may face a court order halting production of some of its CoreValve heart valves.

Angiodynamics Names Smith & Nephew’s DeVivo as Chief Executive

Angiodynamics Inc., the maker of devices for minimally invasive surgery, named Joseph DeVivo president and chief executive officer, giving him the job of reviving sales of catheters and other hospital products.

Edwards Valve Inserted Straight Into Heart Has Improved Results in Study

Elderly patients getting Edwards Lifesciences Corp.’s Sapien heart valve implanted through the ribs as part of an expanded access program reaped more benefit than those observed in the initial trials, a study found.

HeartWare Implantable Pump Wins U.S. FDA Panel’s Backing

HeartWare International Inc.’s implantable pump for heart-transplant candidates won the backing of U.S. advisory panel members who said the device would provide dying patients a lifeline.

HeartWare Implant Pump Met Goals While FDA Questions Data

HeartWare International Inc.’s implantable pump for heart-transplant candidates, under review for approval by U.S. regulators, met its primary goal in studies, according to a report.

HeartWare Shares Rise on Panel Backing of Implantable Pump

HeartWare International Inc. rose the most in more than a year after its implantable pump for heart-transplant candidates gained support from U.S. regulatory advisers who said the device provides dying patients a lifeline.

Edwards Heart Valve Skirts Rib-Cracking for $2.5 Billion

A half decade after Edwards Lifesciences Corp. and Medtronic Inc. introduced devices in Europe that make heart-valve surgery easier to endure, most U.S. patients are waiting for safety data to clear their use.

Edwards Sapien Safely Replaces Aortic Valves at Two Years

Edwards Lifesciences Corp.’s Sapien device replaces damaged aortic heart valves as well as surgery, without cracking open the chest or triggering higher rates of stroke or death after two years, a company-funded study found.

Edwards Wins FDA Advisers' Backing for Wider Sapien Use

Edwards Lifesciences Corp. won the backing of U.S. advisers for an expanded use of the company’s Sapien heart valve as an alternative to open-heart surgery.

"The results exceeded our expectations by a considerable margin, in every category."

- Jason Mills on Jan 30, 2012

San Francisco

New York

Europe

Irvine

J.C. Penney Apologizes in Ad Developed Under Former CEO

Cannibalism Evidence Found at Jamestown Settlement by Scientists

Facebook Revenue Exceeds Estimates on Mobile Advertising

Gold Bull Run Seen Over as Bear Drop Frays Faithful: Commodities

Friends Land in Jail After Dumping Bomb Suspect Backpack